Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06309264 · ClinicalTrials.gov registry record · NA
Comparing Hearing Aid Fitting Methods in Blast-exposed Veterans
A NA study of Auditory Diseases, Central, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 3
- Study locations
NCT06309264 is a NA study of Auditory Diseases, Central that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 80 participants. The trial reports 3 study locations across 1 state.
The verdict
NCT06309264, a NA study of Auditory Diseases, Central, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
Since 2000, at least 250,000 U.S. Service members have experienced a blast-related mild traumatic brain injury. A retrospective analysis of over 100,000 post-9/11 Veterans shows that blast injury more than doubles the risk of a diagnosed auditory problem. Many blast-exposed Veterans experience "functional hearing difficulties" (FHDs): problems in challenging listening environments despite clinically normal hearing as measured by the pure-tone audiogram. VA audiologists have begun using low-gain hearing aids to treat FHDs, but there are no concrete guidelines for this application given standard procedures rely on the pure-tone audiogram. This study proposes a data-driven approach called speech-based audiometry (SBA), which optimizes hearing aid gains from a patient's responses to speech stimuli in aided conditions. This trial will assess the behavioral (speech recognition in noise, subjective listening difficulty) and neurophysiological (functional neuroimaging during a speech recognition task) benefits of low-gain hearing aids programmed conventionally or with SBA among blast-exposed Veterans with FHDs.
Conditions Studied
Interventions
- DEVICE Phonak Lumina P90
Study Locations (3)
California
- VA Loma Linda Healthcare System, Loma Linda, CA - Loma Linda
- VA Greater Los Angeles Healthcare System, Sepulveda, CA - Sepulveda
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06309264
The ClinicalTrials.gov registry entry for NCT06309264 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Auditory Diseases, Central appearing as the primary indexed condition, and to 1 intervention - of which Phonak Lumina P90 is the first listed.
NCT06309264 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06309264 about?
NCT06309264 is a clinical study titled "Comparing Hearing Aid Fitting Methods in Blast-exposed Veterans". Since 2000, at least 250,000 U.S. Service members have experienced a blast-related mild traumatic brain injury. A retrospective analysis of over 100,000 post-9/11 Veterans shows that blast injury more than doubles the risk of a diagnosed auditory problem. Many blast-exposed Veterans experience "func...
What is the current status of trial NCT06309264?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-04-01. Estimated completion is 2028-03-31.
What conditions does trial NCT06309264 study?
This clinical trial studies the following conditions: Auditory Diseases, Central.
What interventions are being tested in trial NCT06309264?
The interventions under investigation include: Phonak Lumina P90 (DEVICE).
Who is sponsoring clinical trial NCT06309264?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06309264 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.